Windlas Biotech Ltd. has announced public offering of 8729024 shares at a price of Rs 5.00 each for Cash at a Premium of Rs 455.00 per share. The gross proceeds of the issue are expected to be Rs 40,153.51 lakhs.
The company's initial public offer (IPO) will open on 04 August 2021 and is expected to close on 06 August 2021, subject to customary closing conditions. The price band of the issue has been fixed at Rs 448.00-460.00 per share.
The IPO includes a fresh Issue of 8729024 Equity Shares of the Company at an price of Rs 460.00 per Equity Share. The company has fixed the minimum bid lot for the issue at 30 shares with bids in multiples of 30.
Windlas Biotech Ltd. anticipates using the proceeds of the issue for Purchase of equipment required for (i) capacity expansion of the existing facility at Dehradun Plant – IV; and (ii) additionof injectables dosage capability at the existing facility at Dehradun PlantII Funding incremental working capital requirements of the Company Repayment/prepayment of certain of the borrowings General corporate purposes.
SBI Capital Markets Limited,IIFL Securities Limited,DAM Capital Advisors Limited as lead manager(s) & Link Intime India Private Limited is the registrar, to the issue.